Literature DB >> 14699504

Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95.

Roland Reinehr1, Dieter Häussinger.   

Abstract

BACKGROUND AND AIMS: Cyclic AMP (cAMP) inhibits bile salt-induced hepatocyte apoptosis; the underlying mechanisms are unclear.
METHODS: The effects of cAMP on taurolithocholate-3-sulfate-(TLCS)- or glycochenodesoxycholate (GCDC)-induced CD95 (Fas/APO-1) activation and apoptosis were studied in 24-hour cultured rat hepatocytes and in perfused rat liver.
RESULTS: TLCS induced a rapid oxidative stress response, c-Jun-N-terminal kinase (JNK) and epidermal growth factor (EGF) receptor (EGF-R) activation, subsequent EGF-R/CD95 association and CD95 tyrosine phosphorylation, CD95 membrane targeting, death-inducing signal complex (DISC) formation and hepatocyte apoptosis. None of these responses was triggered by cAMP; however, cAMP induced H89-sensitive serine/threonine phosphorylation of CD95. Similar data were obtained with GCDC, another proapoptotic bile acid. cAMP did not prevent the TLCS-induced oxidative stress response, JNK activation and EGF-R/CD95 association, however abolished EGF-R activation and subsequent CD95 tyrosine phosphorylation, CD95 membrane trafficking, and DISC formation in a H89-sensitive way. Also in presence of TLCS, cAMP induced rapid Ser/Thr phosphorylation of CD95 within 10 min. The effects of cAMP on the various steps of CD95 activation were also found in the intact perfused rat liver. Evidence is given that a cAMP-induced Ser/Thr phosphorylation favors internalization of CD95.
CONCLUSIONS: Inhibition of bile salt-induced apoptosis by cAMP involves both PKA-dependent Ser/Thr phosphorylation of the CD95 and inhibition of EGF-R activation, which results in an inhibition of CD95 tyrosine phosphorylation, CD95 membrane targeting, and DISC formation. CD95 regulation involves complex phosphorylations with CD95-tyrosine phosphorylation favoring CD95 membrane trafficking and DISC formation, whereas CD95 Ser/Thr phosphorylation inhibits these processes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14699504     DOI: 10.1053/j.gastro.2003.09.044

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  15 in total

1.  Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes.

Authors:  Elaine Studer; Xiqiao Zhou; Renping Zhao; Yun Wang; Kazuaki Takabe; Masayuki Nagahashi; William M Pandak; Paul Dent; Sarah Spiegel; Ruihua Shi; Weiren Xu; Xuyuan Liu; Pat Bohdan; Luyong Zhang; Huiping Zhou; Phillip B Hylemon
Journal:  Hepatology       Date:  2011-11-30       Impact factor: 17.425

2.  Rolipram attenuates bile duct ligation-induced liver injury in rats: a potential pathogenic role of PDE4.

Authors:  Leila Gobejishvili; Shirish Barve; Katja Breitkopf-Heinlein; Yan Li; JingWen Zhang; Diana V Avila; Steven Dooley; Craig J McClain
Journal:  J Pharmacol Exp Ther       Date:  2013-07-25       Impact factor: 4.030

3.  Overexpression of mcl-1 attenuates liver injury and fibrosis in the bile duct-ligated mouse.

Authors:  Alisan Kahraman; Justin L Mott; Steven F Bronk; Nathan W Werneburg; Fernando J Barreyro; Maria E Guicciardi; Yuko Akazawa; Karen Braley; Ruth W Craig; Gregory J Gores
Journal:  Dig Dis Sci       Date:  2008-12-03       Impact factor: 3.199

4.  Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors.

Authors:  Bernhard Svejda; Mark Kidd; Andrew Timberlake; Kathy Harry; Alexander Kazberouk; Simon Schimmack; Ben Lawrence; Roswitha Pfragner; Irvin M Modlin
Journal:  Cancer Sci       Date:  2013-05-24       Impact factor: 6.716

Review 5.  The bile acid TGR5 membrane receptor: from basic research to clinical application.

Authors:  Henri Duboc; Yvette Taché; Alan F Hofmann
Journal:  Dig Liver Dis       Date:  2014-01-09       Impact factor: 4.088

Review 6.  TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?

Authors:  Verena Keitel; Maria Reich; Dieter Häussinger
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

7.  Phosphodiesterase 4 Inhibition as a Therapeutic Target for Alcoholic Liver Disease: From Bedside to Bench.

Authors:  Walter E Rodriguez; Banrida Wahlang; Yali Wang; Jingwen Zhang; Manicka V Vadhanam; Swati Joshi-Barve; Philip Bauer; Robert Cannon; Ali Reza Ahmadi; Zhaoli Sun; Andrew Cameron; Shirish Barve; Claudio Maldonado; Craig McClain; Leila Gobejishvili
Journal:  Hepatology       Date:  2019-06-25       Impact factor: 17.425

Review 8.  Role of cAMP and phosphodiesterase signaling in liver health and disease.

Authors:  Banrida Wahlang; Craig McClain; Shirish Barve; Leila Gobejishvili
Journal:  Cell Signal       Date:  2018-06-11       Impact factor: 4.315

Review 9.  Endocrine and paracrine role of bile acids.

Authors:  Verena Keitel; Ralf Kubitz; Dieter Häussinger
Journal:  World J Gastroenterol       Date:  2008-10-07       Impact factor: 5.742

10.  Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis.

Authors:  Güldeniz Karadeniz; Serefden Acikgoz; Ishak Ozel Tekin; Oge Tascýlar; Banu Dogan Gun; Mustafa Cömert
Journal:  Clinics (Sao Paulo)       Date:  2008-08       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.